Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Antel

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Brain : a Journal of Neurology|July 29, 1998
Improved correlation between scores on the expanded disability status scale and cerebral lesion load in relapsing-remitting multiple sclerosis. Results of the application of new imaging methodsF Riahi, A Zijdenbos, S Narayanan, et al.
Brain : a Journal of Neurology|October 26, 2000
Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosisH Reddy, S Narayanan, R Arnoutelis, et al.
Clinical and Experimental Immunology|January 18, 2006
Altered naive CD4 and CD8 T cell homeostasis in patients with relapsing-remitting multiple sclerosis: thymic versus peripheral (non-thymic) mechanismsD A Duszczyszyn, J D Beck, J Antel, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1988
Crystal and molecular structure of didemnin B, an antiviral and cytotoxic depsipeptideM B Hossain, D van der Helm, J Antel, et al.
International Journal of Peptide and Protein Research|January 1, 1996
Crystal and molecular structure of didemnin A, an antiviral depsipeptideM B Hossain, D Van Der Helm, J Antel, et al.
Neurology|January 6, 2009
Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension studyP O'Connor, G Comi, X Montalban, et al.
AIDS Research and Human Retroviruses|November 18, 2000
HTLV type 1 Tax transduction in microglial cells and astrocytes by lentiviral vectorsS Wrzesinski, R Séguin, Y Liu, et al.
The Pharmacogenomics Journal|September 20, 2006
No evidence for binding of clozapine, olanzapine and/or haloperidol to selected receptors involved in body weight regulationF M Theisen, M Haberhausen, M A Firnges, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2009
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year resultsG Comi, P O'Connor, X Montalban, et al.
Neurology|January 15, 2000
Relating axonal injury to functional recovery in MSH Reddy, S Narayanan, P M Matthews, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Brain : a Journal of Neurology|July 29, 1998
Improved correlation between scores on the expanded disability status scale and cerebral lesion load in relapsing-remitting multiple sclerosis. Results of the application of new imaging methodsF Riahi, A Zijdenbos, S Narayanan, et al.
Brain : a Journal of Neurology|October 26, 2000
Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosisH Reddy, S Narayanan, R Arnoutelis, et al.
Clinical and Experimental Immunology|January 18, 2006
Altered naive CD4 and CD8 T cell homeostasis in patients with relapsing-remitting multiple sclerosis: thymic versus peripheral (non-thymic) mechanismsD A Duszczyszyn, J D Beck, J Antel, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1988
Crystal and molecular structure of didemnin B, an antiviral and cytotoxic depsipeptideM B Hossain, D van der Helm, J Antel, et al.
International Journal of Peptide and Protein Research|January 1, 1996
Crystal and molecular structure of didemnin A, an antiviral depsipeptideM B Hossain, D Van Der Helm, J Antel, et al.
Neurology|January 6, 2009
Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension studyP O'Connor, G Comi, X Montalban, et al.
AIDS Research and Human Retroviruses|November 18, 2000
HTLV type 1 Tax transduction in microglial cells and astrocytes by lentiviral vectorsS Wrzesinski, R Séguin, Y Liu, et al.
The Pharmacogenomics Journal|September 20, 2006
No evidence for binding of clozapine, olanzapine and/or haloperidol to selected receptors involved in body weight regulationF M Theisen, M Haberhausen, M A Firnges, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2009
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year resultsG Comi, P O'Connor, X Montalban, et al.
Neurology|January 15, 2000
Relating axonal injury to functional recovery in MSH Reddy, S Narayanan, P M Matthews, et al.
Pageof 7